Neomi A Shah1,2, Michelle Reid3, Jorge R Kizer4, Ravi K Sharma5, Ravi V Shah6, Vaishnavi Kundel1, Bharath Ambale-Venkatesh7, Zahi A Fayad8, Steven J Shea9,10, Robert C Kaplan2,11, Joao A C Lima7, Susan Redline3,5. 1. Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. 2. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York. 3. Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, Massachusetts. 4. Departments of Medicine, Epidemiology and Biostatistics, San Francisco Veterans Affairs Health Care System and University of California San Francisco, San Francisco, California. 5. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 6. Department of Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts. 7. Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland. 8. Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 9. Columbia University Mailman School of Public Health, Department of Epidemiology, New York, New York. 10. Department of Medicine, Vagelos College of Physicians and Surgeons, New York, New York. 11. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Abstract
STUDY OBJECTIVES: The objectives of this study were to evaluate the independent association between sleep-disordered breathing (SDB) using overnight polysomnography and left ventricular (LV) scar using cardiac magnetic resonance (CMR) with late-gadolinium enhancement in a community-based cohort of the Multi-Ethnic Study of Atherosclerosis. METHODS: Our analytical sample includes 934 participants from the fifth examination of the Multiethnic Study of Atherosclerosis who underwent both polysomnography and CMR. SDB was categorized as follows: no-SDB (apnea-hypopnea index [AHI] < 5 events/h), mild SDB (5 events/h ≤ AHI < 15 events/h), and moderate-severe SDB (AHI ≥ 15 events/h). LV scar was considered present if there was presence of scar on CMR (late-gadolinium enhancement > 0%). Logistic regression with multivariable adjustment for confounders (age, sex, race/ethnicity, body mass index, and cardiometabolic risk factors) was used to examine the independent association of SDB with LV scar. Confounders were identified using directed acyclic graphs. RESULTS: The mean age of our sample was 67.0 ± 8.5 years (SD), with 49% (n = 461) females and a prevalence of SDB (AHI ≥ 5 events/h) of 63% (n = 590). LV scar was more prevalent in individuals with SDB (9.5%) versus those without SDB (3.8%; P < .01), and 88% of all LV scars were clinically unrecognized. After multivariable adjustment, both mild SDB and moderate-severe SDB were independently associated with LV scar (odds ratio, 2.53; 95% confidence interval, 1.13-5.64 and odds ratio, 2.31; 95% confidence interval, 1.01-5.24, respectively). CONCLUSIONS: In a community-based cohort, SDB (including mild) is independently associated with a more than 2-fold increase in the odds of LV scar presence measured using CMR with late-gadolinium enhancement. Most LV scars were clinically unrecognized. The impact of SDB treatment on subclinical myocardial infarction needs to be investigated in future studies.
STUDY OBJECTIVES: The objectives of this study were to evaluate the independent association between sleep-disordered breathing (SDB) using overnight polysomnography and left ventricular (LV) scar using cardiac magnetic resonance (CMR) with late-gadolinium enhancement in a community-based cohort of the Multi-Ethnic Study of Atherosclerosis. METHODS: Our analytical sample includes 934 participants from the fifth examination of the Multiethnic Study of Atherosclerosis who underwent both polysomnography and CMR. SDB was categorized as follows: no-SDB (apnea-hypopnea index [AHI] < 5 events/h), mild SDB (5 events/h ≤ AHI < 15 events/h), and moderate-severe SDB (AHI ≥ 15 events/h). LV scar was considered present if there was presence of scar on CMR (late-gadolinium enhancement > 0%). Logistic regression with multivariable adjustment for confounders (age, sex, race/ethnicity, body mass index, and cardiometabolic risk factors) was used to examine the independent association of SDB with LV scar. Confounders were identified using directed acyclic graphs. RESULTS: The mean age of our sample was 67.0 ± 8.5 years (SD), with 49% (n = 461) females and a prevalence of SDB (AHI ≥ 5 events/h) of 63% (n = 590). LV scar was more prevalent in individuals with SDB (9.5%) versus those without SDB (3.8%; P < .01), and 88% of all LV scars were clinically unrecognized. After multivariable adjustment, both mild SDB and moderate-severe SDB were independently associated with LV scar (odds ratio, 2.53; 95% confidence interval, 1.13-5.64 and odds ratio, 2.31; 95% confidence interval, 1.01-5.24, respectively). CONCLUSIONS: In a community-based cohort, SDB (including mild) is independently associated with a more than 2-fold increase in the odds of LV scar presence measured using CMR with late-gadolinium enhancement. Most LV scars were clinically unrecognized. The impact of SDB treatment on subclinical myocardial infarction needs to be investigated in future studies.
Authors: Raymond Y Kwong; Anna K Chan; Kenneth A Brown; Carmen W Chan; H Glenn Reynolds; Sui Tsang; Roger B Davis Journal: Circulation Date: 2006-06-05 Impact factor: 29.690
Authors: Pamela L Lutsey; Robyn L McClelland; Daniel Duprez; Steven Shea; Eyal Shahar; Mako Nagayoshi; Matthew Budoff; Joel D Kaufman; Susan Redline Journal: Thorax Date: 2015-07-08 Impact factor: 9.139
Authors: Luciano F Drager; Luiz A Bortolotto; Maria Cecília Lorenzi; Adelaide C Figueiredo; Eduardo M Krieger; Geraldo Lorenzi-Filho Journal: Am J Respir Crit Care Med Date: 2005-05-18 Impact factor: 21.405
Authors: Brian T Patt; David Jarjoura; Diane N Haddad; Chandan K Sen; Sashwati Roy; Nicholas A Flavahan; Rami N Khayat Journal: Am J Respir Crit Care Med Date: 2010-07-23 Impact factor: 21.405
Authors: Luciano F Drager; Heno F Lopes; Cristiane Maki-Nunes; Ivani C Trombetta; Edgar Toschi-Dias; Maria Janieire N N Alves; Raffael F Fraga; Jonathan C Jun; Carlos E Negrão; Eduardo M Krieger; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho Journal: PLoS One Date: 2010-08-11 Impact factor: 3.240
Authors: Stefan Buchner; Anna Satzl; Kurt Debl; Andrea Hetzenecker; Andreas Luchner; Oliver Husser; Okka W Hamer; Florian Poschenrieder; Claudia Fellner; Florian Zeman; Günter A J Riegger; Michael Pfeifer; Michael Arzt Journal: Eur Heart J Date: 2013-10-27 Impact factor: 29.983